Role of hypoxia inducible factor-1 in keratinocyte inflammatory response and neutrophil recruitment by Emma Leire et al.
Leire et al. Journal of Inflammation 2013, 10:28
http://www.journal-inflammation.com/content/10/1/28SHORT REPORT Open AccessRole of hypoxia inducible factor-1 in keratinocyte
inflammatory response and neutrophil recruitment
Emma Leire1,2, Josh Olson1, Hart Isaacs3, Victor Nizet1,4 and Andrew Hollands1,5*Abstract
Background: Hypoxia inducible factor-1 (HIF-1) is a major regulator of the cellular adaption to low oxygen stress
and the innate immune function of myeloid cells. Treatment with the novel HIF-1 stabilizing drug AKB-4924 has
been shown to enhance the bactericidal activity of keratinocytes as well as phagocytic cells. In this study, we
sought to investigate the effect of pharmacological boosting of HIF-1 with AKB-4924 in keratinocytes and their
contribution to the innate immune response.
Findings: Treatment with the novel HIF-1 stabilizing drug AKB-4924 can increase keratinocyte production of
pro-inflammatory cytokines in vitro and enhance neutrophil recruitment in vivo.
Conclusions: HIF plays an important role in cytokine production by keratinocytes and in neutrophil recruitment to
the skin. The HIF-boosting drug AKB-4924 has the potential to enhance the immune response even in the complex
environment of bacterial skin infections.
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Hypoxia inducible factor-1 (HIF-1) is a transcription factor
that is a major regulator of cellular adaption to low oxygen
levels [1,2]. More recently, HIF has been recognized to play
a role in host defense, promoting the bactericidal activity
of phagocytic and epithelial cells and supporting innate
immune activities of dendritic cells and mast cells [3-6].
HIF is comprised of a constitutively expressed β subunit that
partners with dynamically regulated α subunits (HIF-1α,
HIF-2α, or HIF-3α), which are unstable under normoxic
conditions [7]. The short half-life of HIF-α subunits re-
flects the activity of a family of oxygen-and iron-dependent
prolyl hydroxylases (PHDs), which direct HIF-α subunits
to proteosomal degradation [8]. A new PHD inhibitor,
AKB-4924, acts as a HIF-1α stabilizing agent to increase
HIF-1 levels and boosts the bactericidal activity of
cultured phagocytes and skin cells against important
bacterial pathogens [9]. Furthermore, local administration
of AKB-4924 in vivo was shown to limit progression of
Staphylococcus aureus skin infection [9]. AKB-4924
has previously been shown to stabilize HIF-1α, and to a* Correspondence: anhollands@ucsd.edu
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reproduction in any medium, provided the orlesser degree HIF-2α, in mouse fibroblasts, demonstrated
by up-regulation of known HIF target genes such as
vascular endothelial growth factor (VEGF) and glucose
transporter-1 [9]. However, the effects of AKB-4924 on
a cellular level in keratinocytes that contribute to the
observed innate immune boosting remain unclear. In
this focused study, we investigated the effect of the HIF-
stabilizing agent AKB-4924 on keratinocytes. Specifically,
the production of VEGF, involved in enhancing permeability
of the local microvasculature [10], interleukin-8 (IL-8),
a C-X-C family chemokine that is the major neutrophil
chemo-attractant in humans [11] and interleukin-6 (IL-6),
a pro-inflammatory cytokine that supports neutrophil
antibacterial activity in the skin, and the role that HIF
plays in neutrophil recruitment in vivo [12].Methods
AKB-4924
AKB-4924 was manufactured as previously described in
a three-step synthesis with a resulting purity of 98% [9].
Structure and purity were confirmed by nuclear magnetic
resonance followed by mass spectrometry. AKB-4924 was
resuspended in dimethyl sulfoxide, pH = 4.2-4.4 to 5 mM
and used at 10 μM unless otherwise indicated [9].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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HaCaT cells (ATCC), a human skin keratinocyte cell line
[13], were plated in 12 well plates in RPMI supplemented
with 10% fetal bovine serum (FBS) and penicillin/strepto-
mycin (Invitrogen) and grown to confluency. The cells were
washed with PBS and fresh media was added containing
10 μM AKB-4924, and/or 1 μg/mL LPS (Sigma) or vehicle
control. Cells were incubated in normoxia (37°C, 5% CO2,
21% O2) or hypoxia (37°C, 5% CO2, 1% O2) for 24 h in a
hypoxia chamber.
Measurement of cytokine production
Following culture under the conditions described above,
supernatant was collected and concentration of IL-6, IL-8
and VEGF was measured by enzyme linked immunosorbent
assay (ELISA) as per the manufacturer’s instructions
(R&D Systems) and expressed as pg/ml.
For in vivo cytokine analysis wildtype (WT) and knockout
(KO) mice were injected intradermally with 5 μg LPS in
100 μl PBS. After 24 h, skin was collected from euthanized
animals using a 10 mm biopsy punch (Miltex) and homoge-
nized as described above. Levels of mouse IL-6 (mIL-6),
mouse VEGF (mVEGF) and the mouse IL-8 homologue
keratinocyte-derived cytokine (KC) in skin homogenate
were determined by ELISA as per the manufacturer’s
directions (R&D). Data were expressed as pg/wound.
HIF-1 keratinocyte knockout mice
Keratinocyte-specific inactivation of HIF-1α was achieved
by cross-breeding K14-cre transgenic mice [14] with
HIF-1α flox/flox mice [15]. In all experiments, cre-negative
littermates served as WTcontrols.
Neutrophil recruitment assays
For neutrophil recruitment studies in WT and KO mice,
animals were administered intradermal injections with
5 μg LPS in 100 μl PBS, or PBS alone as a control, into
the shaved skin of the flank. Each mouse received two
LPS injections and two PBS only injections. Mice were
sacrificed after 24 h and skin was harvested from the site
of injection using a 10 mm biopsy punch (Miltex). One
skin sample per condition from each mouse was fixed in
10% formalin and stained with hematoxylin and eosin
(H&E) by the UCSD histology core facility. Histology
was scored as follows: 0 = no inflammation, 1 = mild
inflammation, 2 = moderate inflammation, 3 = severe
inflammation. The other skin sample of each condition
was resuspended in PBS and homogenized as previously
described [16]. Neutrophil migration was quantified by
a myeloperoxidase (MPO) assay [17]. To enumerate neu-
trophils in mouse skin homogenates, a standard curve with
human neutrophil derived myeloperoxidase was used to
quantify MPO. Human neutrophils were collected by
venipuncture from healthy volunteers and harvested usingPolyMorphPrep according to the manufacturer’s protocol
(Axis-Shield, Norway). For HIF boosting studies utilizing
AKB-4924, CD1 outbred mice were administered intrader-
mal injections with 1 μg LPS in 100 μl PBS, or PBS alone
as a control, into the shaved skin of the flank as described
above, with or without 100 μM AKB-4924.
Statistical analyses
Statistical analyses were performed using the Prism
software from GraphPad (La Jolla, CA). All data were
expressed as mean ± standard deviation and analyzed using
Student’s unpaired t-test or one-way ANOVA.
Ethics approvals
Permission to collect human blood under informed consent
was approved by the UCSD Human Research Protections
Program. All animal experiments were conducted accor-
ding to the guidelines approved by the UCSD Institutional
Animal Care and Use Committee.
Results
Effect of HIF boosting on cytokine production in
keratinocytes
In this study we investigated the effect of HIF boosting on
keratinocyte cytokine production, and we found that
keratinocytes treated with the HIF-1 stabilizer AKB-4924
produced significantly more VEGF, IL-6 and IL-8 compared
to cells treated with vehicle alone (Figure 1A).
HIF boosting in keratinocytes under hypoxic conditions
Skin is hypoxic under baseline conditions, and tissue and
wounds have even lower oxygen levels [5]. To examine
the effect of pharmacological stabilization of HIF-1 under
hypoxic conditions, we treated keratinocytes with AKB-4924
or vehicle control in a hypoxic (1% O2) environment for
24 h. While a modest up-regulation of IL-8 and VEGF
under hypoxia compared to normoxia did not achieve
statistical significance, and a significant decrease in IL-6
was seen during hypoxia compared to normoxia, hypoxia
plus the administration of AKB-4924 resulted in significant
increases in VEGF, IL-6 and IL-8 (Figure 1B). A significant
increase in VEGF and IL-6 were also observed in hypoxia
plus AKB-4924 compared to hypoxia alone.
HIF boosting in keratinocytes in conjunction with an
inflammatory stimulus
To investigate the effects of HIF boosting by AKB-4924
in keratinocytes under the influence of an inflammatory
stimulus, cells were treated with 1 μg/mL LPS and
AKB-4924 or vehicle control for 24 h under normoxic
conditions. IL-8, but not IL-6 production, was signifi-
cantly increased in response to LPS alone (Figure 1C).
A modest, non-significant increase of VEGF was observed
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Figure 1 AKB-4924 boosts production of VEGF, IL-6 and IL-8 by HaCat keratinocytes in vitro. A Cytokine production in control cells after
the addition of vehicle (black bars) or after the addition of 10 μM AKB-4924 (white bars). B Cytokine production under normoxia (black bars),
hypoxia (white bars), or hypoxia with AKB-4924 (gray bars). C Cytokine production in control cells (black bars), cells stimulated with LPS (white
bars), or cells treated with LPS in conjunction with AKB-4924 (gray bars). D Cytokine production by cells under hypoxia alone (black bars), LPS
stimulation under hypoxia (white bars), or LPS stimulation in conjunction with AKB-4924 under hypoxia (gray bars). For all panels, * indicates
P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001 as determined by student’s t-test or one-way ANOVA.
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higher levels of VEGF, IL-6, and IL-8 compared to control
cells. VEGF and IL-6 production were also significantly
higher in cells stimulated with LPS in conjunction with
AKB-4924 treatment compared to cells stimulated with
LPS alone. Treatment with AKB-4924 did not significantly
increase IL-8 levels above those of LPS treatment alone,
suggesting that this level of LPS stimulation results in
already maximal IL-8 expression.
HIF boosting in keratinocytes in conjunction with an
inflammatory stimulus under hypoxic conditions
To more closely mimic the hypoxic conditions of an
infected skin lesion, keratinocytes were stimulated with
1 μg/mL LPS, with or without the addition of AKB-4924,
in 1% O2. Similar to normoxic conditions, IL-8 but not
VEGF or IL-6 production was significantly increased in re-
sponse to LPS under hypoxic conditions (Figure 1D).
VEGF, IL-6 and IL-8 were all significantly higher after
stimulation with LPS in conjunction with AKB-4924 com-
pared to control cells, suggesting that AKB-4924 can fur-
ther boost HIF-regulated cytokine production beyond
that supported by hypoxia alone. As seen with LPS
stimulation alone, IL-8 levels were not significantly in-
creased with AKB-4924 treatment compared to LPS in
hypoxia without AKB-4924.
HIF boosting with AKB-4924 enhances neutrophil
recruitment in vivo
To determine the in vivo effect of enhanced chemokine
and VEGF production by HIF-boosted keratinocytes on
neutrophil recruitment, we injected 1 μg LPS intradermallyinto the flanks of WT mice, with or without AKB-4924.
Neutrophil recruitment was determined by quantifying
MPO in tissue homogenates 24 h after LPS treatment.
AKB-4924 significantly increased the recruitment of
neutrophils to the site of LPS injection (Figure 2A). Histo-
logical analysis confirmed an inflammatory response con-
sisting of primarily neutrophils, with some macrophages
and lymphocytes also present (Figure 2B). No difference
was observed in the type of cells recruited, but an overall
increase in inflammatory response was seen in AKB-4924
treated animals, as shown by histological score (Figure 2C).
HIF-1α in keratinocytes contributes to neutrophil
recruitment and cytokine production in vivo
Mice with specific deletion of HIF-1α in keratinocytes
have previously been shown to develop significantly larger
necrotic skin lesions with higher bacterial load compared to
WT mice [5]. To study the role of HIF-1α in keratinocytes
in recruitment of neutrophils to an inflammatory stimulus,
WT and keratinocyte-specific HIF-1α KO mice were
injected intradermally with a high dose (5 μg) of LPS.
Significantly fewer neutrophils were recruited to the site
of injection in HIF-1α KO mice compared to WT controls
(Figure 3A). Histological analysis confirmed a strong
inflammatory response in WT mice (Figure 3B). No differ-
ences were observed in the cell types recruited in WT and
KO animals, with the inflammatory response consisting
primarily of neutrophils at this timepoint.
To determine whether HIF-1α in keratinocytes plays
an essential role in cytokine production in vivo, WT and
KO mice were injected intradermally with LPS and 24 h
post-injection, skin tissue was homogenized and used
A B
C
Figure 3 HIF-1α KO mice have reduced response to LPS in vivo. A Neutrophil recruitment to the site of LPS injection as determined by MPO
assay. B H&E stained section of mouse skin injected with LPS, 24 h post-injection in low and high power magnification. Scale bars = 50 µm.
C Amount of mVEGF, mIL-6, and KC in mouse skin, 24 h post-injection with LPS. * indicates P < 0.05.
A B C
Figure 2 AKB-4924 enhances neutrophil recruitment in vivo. A Neutrophil recruitment to the site of LPS injection as determined by MPO
assay. B H&E stained section of mouse skin injected with LPS and AKB-4924 or LPS and vehicle control, 24 h post-injection in low and high
power magnification. Scale bars = 50 µm. C Histological scoring of H&E stained skin sections. * indicates P < 0.05.
Leire et al. Journal of Inflammation 2013, 10:28 Page 4 of 6
http://www.journal-inflammation.com/content/10/1/28
Leire et al. Journal of Inflammation 2013, 10:28 Page 5 of 6
http://www.journal-inflammation.com/content/10/1/28for ELISA. At this time point no difference in mVEGF
was observed between WT and KO mice, however
significantly lower levels of mIL-6 and the murine IL-8
homologue KC were produced in KO mice (Figure 3C).
No significant difference in levels of mVEGF, mIL-6, or
KC was observed between WT and KO mock (PBS)
treated animals.
Discussion
In this study we investigated specific effects of the HIF-
boosting agent AKB-4924 in keratinocytes in tissue culture
conditions mimicking those found in vivo including hypoxia
and exposure to toll like receptor (TLR) agonist, LPS. In
addition, we investigated HIF-boosting with AKB-4924
in vivo. Under most circumstances, AKB-4924 significantly
increased keratinocyte production of VEGF, IL-6, and IL-8
(Figure 1), which are known to contribute to neutrophil
migration and activation, vascular permeability, wound
healing and skin cell proliferation. While a decrease in
IL-6 was observed in hypoxia compared to normoxia
(Figure 1B), treatment with AKB-4924 not only reversed
this decrease in IL-6 but also resulted in a significant
increase in IL-6 levels compared to normoxia. This finding
suggests that additional cellular changes during the shift
to hypoxic conditions, and not HIF levels alone, can
contribute to altered cytokine production in keratinocytes.
Our data showed that AKB-4924 is capable of boosting
keratinocyte production of cytokines involved in the
inflammatory response beyond that of immune stimuli
alone under both hypoxia and normoxia. IL-8 levels were
not increased with AKB-4924 beyond those seen with LPS
stimulation in normoxia or hypoxia suggesting that IL-8
may already be maximally expressed in keratinocytes
exposed to the TLR agonist LPS. These findings suggest
that AKB-4924 has the potential to further boost the
keratinocyte response supporting neutrophil recruitment,
even in an environment where inflammatory stimuli and
hypoxia are already acting to stimulate HIF pathways, as
corroborated in vivo in Figure 2 with analysis of MPO
levels in mouse skin and histological observation. While it
is not currently known whether HIF has a direct effect on
MPO production by neutrophils, a correlation between
MPO in mouse skin samples and histological score of
inflammation was observed (Figure 2).
This enhancement of neutrophil recruitment likely
contributes to the observed ability of local AKB-4924
administration to enhance bacterial clearance in mouse
skin infections, synergizing with increases in specific
keratinocyte bactericidal effectors such as cathelicidin
peptides [9], and direct effects of the HIF-boosting drug to
activate the antimicrobial capacity of the neutrophils
following their recruitment.
Mice lacking HIF-1α in their keratinocytes have previ-
ously been shown to develop larger necrotic lesions andhad decreased capacity to clear bacteria [5]. Here we found
that HIF-1α keratinocyte KO mice recruited less neu-
trophils to the site of administration of an inflammatory
stimulus (LPS) compared to WT mice, while producing
less mIL-6 and KC than their WT counterparts (Figure 3).
This finding demonstrates that while other cell types may
contribute to cytokine production in the skin, HIF-1α
in keratinocytes plays an important role in recruitment
of neutrophils. This delay in the kinetics of neutrophil
recruitment resulting from a reduced chemokine response
in keratinocytes further explains the innate immune defect
in the HIF-1α keratinocyte KO mouse. Previous work
with S. aureus bacterial challenge has shown that even
in keratinocyte HIF-1α deficiency, the expanding necrotic
lesion is ultimately replete with neutrophils at later time
points [5].
Together, these findings support the potential of AKB-
4924 to boost keratinocyte innate immune responses that
promote neutrophil recruitment to inflammatory stimuli.
Coupled with their ability to stimulate myeloid cell
bactericidal function [3,9,18], HIF-boosting compounds
such as AKB-4924 may represent a useful adjunctive
therapy for bacterial infections in an age of ever increasing
resistance to front-line antibiotic agents.
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